Endocrinol Metab.  2017 Sep;32(3):396-397. 10.3803/EnM.2017.32.3.396.

Letter: Utility of the Visceral Adiposity Index and Hypertriglyceridemic Waist Phenotype for Predicting Incident Hypertension (Endocrinol Metab 2017;32:221-9, Mohsen Janghorbani et al.)

• Rhee EJ

• KMID: 2389822
• DOI: http://doi.org/10.3803/EnM.2017.32.3.396

Abstract

No abstract available.

MeSH Terms

Adiposity*
Hypertension*
Hypertriglyceridemic Waist*
Phenotype*

Reference

1. Despres JP. Is visceral obesity the cause of the metabolic syndrome? Ann Med. 2006; 38:52–63.

2. Lebovitz HE, Banerji MA. Point: visceral adiposity is causally related to insulin resistance. Diabetes Care. 2005; 28:2322–2325.

3. Bjorntorp P. Metabolic implications of body fat distribution. Diabetes Care. 1991; 14:1132–1143.

4. Amato MC, Giordano C, Galia M, Criscimanna A, Vitabile S, Midiri M, et al. Visceral Adiposity Index: a reliable indicator of visceral fat function associated with cardiometabolic risk. Diabetes Care. 2010; 33:920–922.

5. Ding Y, Gu D, Zhang Y, Han W, Liu H, Qu Q. Significantly increased visceral adiposity index in prehypertension. PLoS One. 2015; 10:e0123414.

6. Oh JY, Sung YA, Lee HJ. The visceral adiposity index as a predictor of insulin resistance in young women with polycystic ovary syndrome. Obesity (Silver Spring). 2013; 21:1690–1694.

7. Park HJ, Kim J, Park SE, Park CY, Lee WY, Oh KW, et al. Increased risk of subclinical atherosclerosis associated with high visceral adiposity index in apparently healthy Korean adults: the Kangbuk Samsung Health Study. Ann Med. 2016; 48:410–416.

8. Lemieux I, Pascot A, Couillard C, Lamarche B, Tchernof A, Almeras N, et al. Hypertriglyceridemic waist: a marker of the atherogenic metabolic triad (hyperinsulinemia; hyperapolipoprotein B; small, dense LDL) in men? Circulation. 2000; 102:179–184.

9. Moon BS, Park HJ, Lee MK, Jeon WS, Park SE, Park CY, et al. Increased association of coronary artery calcification in apparently healthy Korean adults with hypertriglyceridemic waist phenotype: the Kangbuk Samsung Health Study. Int J Cardiol. 2015; 194:78–82.

10. Han KJ, Lee SY, Kim NH, Chae HB, Lee TH, Jang CM, et al. Increased risk of diabetes development in subjects with the hypertriglyceridemic waist phenotype: a 4-year longitudinal study. Endocrinol Metab (Seoul). 2014; 29:514–521.

11. Janghorbani M, Salamat MR, Aminorroaya A, Amini M. Utility of the visceral adiposity index and hypertriglyceridemic waist phenotype for predicting incident hypertension. Endocrinol Metab (Seoul). 2017; 32:221–229.

12. Seo MH, Rhee EJ. Metabolic and cardiovascular implications of a metabolically healthy obesity phenotype. Endocrinol Metab (Seoul). 2014; 29:427–434.

13. Phillips CM. Metabolically healthy obesity across the life course: epidemiology, determinants, and implications. Ann N Y Acad Sci. 2017; 1391:85–100.